Add to ORKGLow-dose aspirin (75 – 325 mg per day) is widely used in the prevention of myocardial infarction or ischemic stroke ( 1,2). In Western countries, 6 to 12 % of the general population is exposed to low-dose aspirin ( 3,4) and it is estimated that during the pas
OBJECTIVE: To evaluate the efficacy of aspirin for the treatment and prevention of ischemic stroke a...
Aspirin was first synthesised 100 years ago and its preparation and marketing is generally reckoned ...
Aspirin was first synthesised 100 years ago and its preparation and marketing is generally reckoned ...
Aspirin reduces the risk of non-fatal stroke, non-fatal myocardial infarction and vascular death in ...
The online version of this article, along with updated information and services, is located on th
textabstractThe use of acetylsalicylic acid, better known as aspirin, dates back to the Egyptians in...
Low dose aspirin is effective, safe, and economical in the secondary prevention of cardiovascular di...
Low-dose aspirin has been shown to be effective in preventing about one-fifth of atherothrombotic va...
Aspirin used in cardiovascular disease is probably the best evaluated and the most highly cost effec...
Aspirin used in cardiovascular disease is probably the best evaluated and the most highly cost effec...
Background Low-dose aspirin is recommended to reduce the risk of cardiovascular dis...
Cardiovascular disease (CVD) is a leading cause of mortality.1 For example, in 2000, it accounted di...
OBJECTIVE: To review current information relevant to the use of aspirin for preventing vascular deat...
Cardiovascular disease (CVD) is a leading cause of mortality.1 For example, in 2000, it accounted di...
• In patients with a history of cardiovascular disease (CVD), aspirin therapy reduces the risk of se...
OBJECTIVE: To evaluate the efficacy of aspirin for the treatment and prevention of ischemic stroke a...
Aspirin was first synthesised 100 years ago and its preparation and marketing is generally reckoned ...
Aspirin was first synthesised 100 years ago and its preparation and marketing is generally reckoned ...
Aspirin reduces the risk of non-fatal stroke, non-fatal myocardial infarction and vascular death in ...
The online version of this article, along with updated information and services, is located on th
textabstractThe use of acetylsalicylic acid, better known as aspirin, dates back to the Egyptians in...
Low dose aspirin is effective, safe, and economical in the secondary prevention of cardiovascular di...
Low-dose aspirin has been shown to be effective in preventing about one-fifth of atherothrombotic va...
Aspirin used in cardiovascular disease is probably the best evaluated and the most highly cost effec...
Aspirin used in cardiovascular disease is probably the best evaluated and the most highly cost effec...
Background Low-dose aspirin is recommended to reduce the risk of cardiovascular dis...
Cardiovascular disease (CVD) is a leading cause of mortality.1 For example, in 2000, it accounted di...
OBJECTIVE: To review current information relevant to the use of aspirin for preventing vascular deat...
Cardiovascular disease (CVD) is a leading cause of mortality.1 For example, in 2000, it accounted di...
• In patients with a history of cardiovascular disease (CVD), aspirin therapy reduces the risk of se...
OBJECTIVE: To evaluate the efficacy of aspirin for the treatment and prevention of ischemic stroke a...
Aspirin was first synthesised 100 years ago and its preparation and marketing is generally reckoned ...
Aspirin was first synthesised 100 years ago and its preparation and marketing is generally reckoned ...